Company: Japan National Institute of Health Sciences
Job title: Chief, Division of Molecular Target and Gene Therapy Products
Dr. Mikihiko Naito is currently the chief of the division of Molecular Target and Gene Therapy Products in National Institute of Health Sciences in Japan. After he obtained his Ph.D. degree in the University of Tokyo, he studied anti-cancer drug resistance, cell death and anti-apoptotic proteins in the Institute of Molecular and Cellular Biology, the University of Tokyo. Then he moved his lab to the National Institute of Health Sciences, and established the protein knockdown technology with SNIPER compounds.